Formula Growth’s Expensify EXFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
875,000
-15,000
-2% -$16.8K 0.55% 73
2026
Q1
$774K Sell
890,000
-10,000
-1% -$11.9K 0.35% 99
2025
Q4
$1.36M Sell
900,000
-250,000
-22% -$396K 0.52% 76
2025
Q3
$2.13M Hold
1,150,000
0.76% 55
2025
Q2
$2.98M Buy
1,150,000
+150,000
+15% +$383K 1.13% 30
2025
Q1
$3.04M Buy
1,000,000
+50,000
+5% +$174K 1.23% 26
2024
Q4
$3.18M Buy
950,000
+15,000
+2% +$40.3K 1.08% 37
2024
Q3
$1.83M Buy
935,000
+235,000
+34% +$488K 0.63% 66
2024
Q2
$1.04M Buy
700,000
+50,000
+8% +$78.8K 0.38% 86
2024
Q1
$1.2M Buy
650,000
+125,000
+24% +$237K 0.38% 88
2023
Q4
$1.3M Buy
525,000
+50,000
+11% +$129K 0.42% 93
2023
Q3
$1.54M Buy
475,000
+275,000
+138% +$1.49M 0.53% 75
2023
Q2
$1.6M Buy
200,000
+20,000
+11% +$147K 0.51% 74
2023
Q1
$1.47M Buy
+180,000
New +$1.6M 0.47% 83

Other funds holding EXFY

Formula Growth's EXFY Position: Q2 2026 in Review

Formula Growth reduced its Expensify (EXFY) stake by 1.7% in Q2 2026, selling an estimated $16.8K and leaving 875,000 shares worth $1.57M. The position accounts for 0.55% of the portfolio, ranked #73.

Formula Growth first reported a position in EXFY in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.18M in Q4 2024. 101 funds tracked by Wall St. Rank hold EXFY as of Q2 2026.

  • Formula Growth held 875,000 shares of Expensify worth $1.57M as of Q2 2026.
  • Formula Growth sold 15,000 Expensify shares in Q2 2026, an estimated $16.8K.
  • Expensify made up 0.55% of Formula Growth's portfolio in Q2 2026, its #73 holding.
  • Formula Growth first reported a position in Expensify in Q1 2023 and has held it in 14 quarters since.
  • Formula Growth's Expensify position peaked at $3.18M in Q4 2024.
  • 101 funds tracked by Wall St. Rank held Expensify as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.